1. Prostate cancer vaccines: the long road to clinical application

   • Constantin N. Baxevanis
   • Michael Papamichail
   • Sonia A. Perez

   Review 19 February 2015 Pages: 401 - 408

   

2. DNAM-1-based chimeric antigen receptors enhance T cell effector function and exhibit in vivo efficacy against melanoma

   • Ming-Ru Wu
   • Tong Zhang
   • Charles L. Sentman

   Original Article 31 December 2014 Pages: 409 - 418

   

3. Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma

   • Elias J. Sayour
   • Pat McLendon
   • Duane A. Mitchell

   Original Article 03 January 2015 Pages: 419 - 427

   

4. Inhibition of induced nitric oxide synthase enhances the anti-tumor effects on cancer immunotherapy using TLR7 agonist in mice

   • Hiroyasu Ito
   • Tatsuya Ando
   • Mitsuru Seishima

   Original Article 08 January 2015 Pages: 429 - 436

   

5. Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008)

   • Mario E. Lacouture
   • John C. Morris
   • Joan Guitart

   Original Article 13 January 2015 Pages: 437 - 446

   

6. Enhancement of glioma-specific immunity in mice by “NOBEL”, an insulin-like growth factor 1 receptor antisense oligodeoxynucleotide

   • Mélanie Morin-Brureau
   • Kirsten M. Hooper
   • D. Craig Hooper

   Original Article 13 January 2015 Pages: 447 - 457

   

7. The prognostic significance of stable disease following high-dose interleukin-2 (IL-2) treatment in patients with metastatic melanoma and renal cell carcinoma

   • Tasha Hughes
   • Matthew Klairmont
   • Howard L. Kaufman

   Original Article 22 January 2015 Pages: 459 - 465

   

8. Local expression of complement factor I in breast cancer cells correlates with poor survival and recurrence

   • Marcin Okroj
   • Emelie Holmquist
   • Anna M. Blom

   Original Article 25 January 2015 Pages: 467 - 478

   

9. Strengthened tumor antigen immune recognition by inclusion of a recombinant Eimeria antigen in therapeutic cancer vaccination

   • Dionisia Quiroga
   • Yasser A. Aldhamen
   • Andrea Amalfitano

   Original Article 06 February 2015 Pages: 479 - 491

   

10. Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer: dose-related immune boosting and suppression

    • Masanori Noguchi
    • Gaku Arai
    • Kyogo Itoh

    Original Article 07 February 2015 Pages: 493 - 505

    

11. Low-dose cyclophosphamide enhances antigen-specific CD4⁺ T cell responses to NY-ESO-1/ISCOMATRIX™ vaccine in patients with advanced melanoma

    • Oliver Klein
    • Ian D. Davis
    • Jonathan Cebon

    Original Article 07 February 2015 Pages: 507 - 518

    

12. “Tumor immunology meets oncology” (TIMO) X, May 23–24, 2014, Halle/Saale, Germany

    • Dagmar Quandt
    • Barbara Seliger

    Meeting Report 14 February 2015 Pages: 519 - 526

13. Acknowledgement

    ACKNOWLEDGEMENT TO REVIEWERS 07 March 2015 Pages: 527 - 530